Add to ORKGPurpose: Identify medications prescribed to manage NAS due to opioids and /or amphetamines. Evaluate average daily medication wean rates. Assess length of stay (LOS) and length of treatment (LOT)https://digitalcommons.centracare.com/pharmacy_posters/1003/thumbnail.jp
Abstract Background: The number of babies born with Neonatal Abstinence Syndrome (NAS) has had a dra...
AIM: To ascertain the present management of neonatal abstinence syndrome (NAS) in neonatal units in ...
This thesis will explore the research on interventions used to manage neonatal abstinence syndrome...
Purpose: Neonates suffering from NAS receive NMS to treat withdrawal symptoms associated with this d...
Neonatal abstinence syndrome (NAS) is becoming more and more prevalent today. The number of women wh...
Neonatal abstinence syndrome (NAS) is a disease that impacts drug-exposed infants and describes an a...
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop aft...
Background: Newborns diagnosed with Neonatal Abstinence Syndrome (NAS) often experience extreme symp...
The scholarly project will provide an evidence-based guideline for the pharmacologic management of i...
Opioid use in pregnant women has increased over the last decade. Following birth, infants with in ut...
The impact of drug use by mothers to fetus’ in utero is critical not only to their growth and develo...
Neonatal abstinence syndrome (NAS) is a condition affecting newborns exposed to an opioid in utero. ...
Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstine...
There are currently no published scoring instruments with prior empirical evidence to support the va...
Opioid use disorder among pregnant women and women of reproductive age has quadrupled in the U.S.. G...
Abstract Background: The number of babies born with Neonatal Abstinence Syndrome (NAS) has had a dra...
AIM: To ascertain the present management of neonatal abstinence syndrome (NAS) in neonatal units in ...
This thesis will explore the research on interventions used to manage neonatal abstinence syndrome...
Purpose: Neonates suffering from NAS receive NMS to treat withdrawal symptoms associated with this d...
Neonatal abstinence syndrome (NAS) is becoming more and more prevalent today. The number of women wh...
Neonatal abstinence syndrome (NAS) is a disease that impacts drug-exposed infants and describes an a...
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop aft...
Background: Newborns diagnosed with Neonatal Abstinence Syndrome (NAS) often experience extreme symp...
The scholarly project will provide an evidence-based guideline for the pharmacologic management of i...
Opioid use in pregnant women has increased over the last decade. Following birth, infants with in ut...
The impact of drug use by mothers to fetus’ in utero is critical not only to their growth and develo...
Neonatal abstinence syndrome (NAS) is a condition affecting newborns exposed to an opioid in utero. ...
Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstine...
There are currently no published scoring instruments with prior empirical evidence to support the va...
Opioid use disorder among pregnant women and women of reproductive age has quadrupled in the U.S.. G...
Abstract Background: The number of babies born with Neonatal Abstinence Syndrome (NAS) has had a dra...
AIM: To ascertain the present management of neonatal abstinence syndrome (NAS) in neonatal units in ...
This thesis will explore the research on interventions used to manage neonatal abstinence syndrome...